Skip to main content
. 2021 Apr 9;97(4):161–196. doi: 10.2183/pjab.97.010

Table 10.

Aβ, tocopherol, and phospholipid hydroperoxide in the plasma and red blood cells (RBCs) of patients with Alzheimer’s disease (AD) and control subjects1

  Control subjects Patients with AD
Plasma
 Aβ (fmol/mL plasma)
  Aβ40 81.2 ± 9.8 103.6 ± 11.8
  Aβ42 18.5 ± 2.8 25.0 ± 5.3
  Aβ42/Aβ40 0.3 ± 0.0 0.3 ± 0.1
 Tocopherol (nmol/mL plasma)
  α-Toc 41.3 ± 3.9 38.4 ± 3.5
 Phospholipid hydroperoxide (pmol/mL plasma)
  PCOOH 29.8 ± 3.7 34.6 ± 5.4
  (µmol/mol phospholipid)
  PCOOH 25.3 ± 4.2 28.9 ± 4.8
RBC
 Tocopherol (nmol/mL packed cells)
  α-Toc 16.8 ± 2.1 16.3 ± 1.8
 Phospholipid hydroperoxide (pmol/mL packed cells)
  PCOOH 9.6 ± 1.5 44.4 ± 10.42
  PEOOH 12.5 ± 2.3 37.6 ± 6.02
  PLOOH4 22.1 ± 3.6 82.0 ± 13.02
  (µmol/mol phospholipid)
  PCOOH 5.2 ± 0.9 50.7 ± 29.6
  PEOOH 6.6 ± 1.2 26.1 ± 7.93
  PLOOH 11.8 ± 2.0 76.7 ± 37.3

1Means ± SEM; n = 18. RBC and plasma PLOOH data were extracted from the PLOOH data (n = 28) from our previous study.116)

2,3Significantly different from control subjects: p < 0.001, p < 0.05.

4PLOOH is the sum of PCOOH and PEOOH.

α-Toc, α-Tocopherol; PCOOH, phosphatidylcholine hydroperoxide; PEOOH, phosphatidylethanolamine hydroperoxide; PLOOH, phospholipid hydroperoxide.

Adapted with permission from Ref. 115. Copyright 2016 IOS Press.